- Home
- BST vs BLFS Comparison
BST vs BLFS Comparison
Compare BST & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BST
- BLFS
- Stock Information
- Founded
- BST 2014
- BLFS 1987
- Country
- BST United States
- BLFS United States
- Employees
- BST N/A
- BLFS N/A
- Industry
- BST Finance Companies
- BLFS Medical/Dental Instruments
- Sector
- BST Finance
- BLFS Health Care
- Exchange
- BST Nasdaq
- BLFS Nasdaq
- Market Cap
- BST 1.4B
- BLFS 1.2B
- IPO Year
- BST N/A
- BLFS 1989
- Fundamental
- Price
- BST $41.91
- BLFS $26.59
- Analyst Decision
- BST
- BLFS Strong Buy
- Analyst Count
- BST 0
- BLFS 7
- Target Price
- BST N/A
- BLFS $30.86
- AVG Volume (30 Days)
- BST 94.2K
- BLFS 358.7K
- Earning Date
- BST 01-01-0001
- BLFS 11-11-2025
- Dividend Yield
- BST 7.16%
- BLFS N/A
- EPS Growth
- BST N/A
- BLFS N/A
- EPS
- BST N/A
- BLFS N/A
- Revenue
- BST N/A
- BLFS $93,468,000.00
- Revenue This Year
- BST N/A
- BLFS $26.07
- Revenue Next Year
- BST N/A
- BLFS $16.86
- P/E Ratio
- BST N/A
- BLFS N/A
- Revenue Growth
- BST N/A
- BLFS 68.16
- 52 Week Low
- BST $27.87
- BLFS $19.10
- 52 Week High
- BST $41.99
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- BST 69.87
- BLFS 60.68
- Support Level
- BST $40.61
- BLFS $24.33
- Resistance Level
- BST $41.64
- BLFS $26.40
- Average True Range (ATR)
- BST 0.43
- BLFS 0.93
- MACD
- BST 0.04
- BLFS 0.04
- Stochastic Oscillator
- BST 94.67
- BLFS 78.99
About BST BlackRock Science and Technology Trust of Beneficial Interest
BlackRock Science and Technology Trust is a closed-end management investment company. Its investment objective is to provide income and total return through a combination of current income, current gains, and long-term capital appreciation. It focuses on investing, under a normal market condition in equity securities of science and technology companies.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.